Drug Search Results

Rebamipide

Alternative Names: rebamipide, mucosta, opc-12759, opc 12759, opc12759
Latest Update: 2024-03-12
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: STAT3 Inhibitor,IL1A Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Otsuka
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rebamipide

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Edema|Gastritis

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
CTR20213424	P1	Not yet recruiting	Gastritis\|Edema	None

Recent News Events

Date	Type	Title
03/12/2024	PubMed	High-Performance Liquid Chromatography (HPLC) Method Validation for Identifying and Quantifying Rebamipide in Ethosomes.
03/12/2024	PubMed	Rebamipide Prevents the Hemoglobin Drop Related to Mucosal-Damaging Agents at a Level Comparable to Proton Pump Inhibitors.
01/01/2024	PubMed	[A case of hepatic portal venous gas and upper gastrointestinal mucosal injury due to accidental ingestion of hydrogen peroxide].
09/08/2023	News Article	Gastric Mucosal Protective Agent market research report was developed using extensive primary and secondary research with estimated CAGR 8.1% for Period 2023-2030
05/31/2019	News Article	Mucosta - API Insight, 2019 - ResearchAndMarkets.com
02/19/2019	News Article	Mucosta - Drug Insight, 2019 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions